How to cite:
Sofyan Hidayatulloh (2021). Docking Molecular Simulation of
Secondary Metabolic Compounds Annona Muricata as Anti-Cancer.
Journal Eduvest. 1(11): 1196-1202
E-ISSN:
2775-3727
Published by:
https://greenpublisher.id/
Eduvest Journal of Universal Studies
Volume 1 Number 11, November 2021
p- ISSN 2775-3735 e-ISSN 2775-3727
DOCKING MOLECULAR SIMULATION OF SECONDARY
METABOLIC COMPOUNDS
ANNONA MURICATA
AS ANTI-
CANCER
Sofyan Hidayatulloh
Muhammadiyah Malang University, Indonesia
ARTICLE INFO ABSTRACT
Received:
October, 26
th
2021
Revised:
November, 16
th
2021
Approved:
November, 18
th
2021
This study aims to test and determine the affinity and
molecular mechanism of Annona muricata to COX-2
target protein, which can be used to test the potential of
Annona muricata as an anticancer drug using the
molecular docking in silico method (computer modeling).
By identifying and optimizing guide molecules in the drug
discovery process, this computational chemical technique
can be utilized to accelerate the selection of compounds
to be isolated and synthesized. The research use
descriptive quantitative as a research design and the
experimental factorial design as an approach. The results
of this study indicate that curcumin and its analogues
have potential to became anticancer, and can be used for
further drug development related to anticancer.
KEYWORDS
Cancer, Anti-Cancer, Annona Muricata
This work is licensed under a Creative Commons
Attribution-ShareAlike 4.0 International
INTRODUCTION
Cancer is a disease that does not distinguish between one social status and the
other and can attack anyone and arises due to abnormal growth of body tissue cells that
become cancer cells in their development which can spread to other parts of the body
which leads to death. Cancer arises from the transformation of normal cells into tumor
cells in a multistage process that generally progresses from precancerous lesions to
malignant tumors (Sirait and Sulistiowati, 2014)
Sofyan Hidayatulloh
Docking Molecular Simulation of Secondary Metabolic Compounds Annona Muricata
as Anti-Cancer 1197
Cancer is a major public health problem worldwide and the second leading cause
of death in the United States. In 2017, the American Cancer Society (ACS) estimated the
number of cancer cases was 1.68 million with 4,600 new cancer diagnoses per day and
600,920 cancer deaths (Siegel et al., 2017). Nationally, the prevalence of cancer in people
of all ages in Indonesia in 2013 was 1.4‰ or an estimated 347,792 people, while for East
Java Province it was 61,230 people (Rio and Suci, 2017).
COX-2 is an enzyme that plays a role in the metabolism of arachidonic acid in
cell membranes. Arachidonic acid metabolism is considered to play a very important role
in the occurrence of carcinogenesis. This metabolic pathway is associated with the
formation of prostanoids. Prostanoids belong to the subclass of eicosanoids which are
converted into prostaglandins, thromboxane and prostacyclin (Singh et al., 2010).
Cyclooxsigenase-2 (COX-2) is a key enzyme in the conversion of arachidonic acid to
prostaglandins which was first identified 20 years ago. Several studies have suggested the
involvement of prostanoids in the pathogenesis of cancer (Grösch et al., 2006, p. 2). In
vitro studies have shown that growth factors, tumor promoters and oncogenes induce
prostanoid synthesis (Singh et al., 2010). Other studies, through in vivo studies, have
shown that arachidonic acid metabolism via the cyclooxygenase pathway is increased in
some tumor events in humans and is thought to be mediated by the induction of the COX-
2 enzyme (Chen et al., 2018; Kern et al., 2006).
The most successful therapies for localized and non-metastatic cancers are
surgery and radiotherapy, but they are not effective if the cancer has spread throughout
the body. Cancer treatments (Chemotherapy, hormone, and biologic therapy) can reach
any organ in the body infected by cancer cells. through the bloodstream. Until now these
drugs are the best treatment of choice for metastatic cancer (Chabner and Roberts, 2005).
Chemotherapy treatment for cancer still has a drawback that besides destroying cancer
cells, it also affects normal cells with high growth rates, such as hair follicles, bone
marrow, and gastrointestinal tract cells, causing side effects typical of chemotherapy.
Because of this, it is necessary to find new treatments that selectively kill cancer cells
without affecting normal cells.
The Annona muricata tree, similar to other Annona species, including Annona
squamosa and Annona reticulata is widely used as traditional medicine for various
diseases, especially cancer and parasitic infections. Phytochemical tests state that
annonaceous acetogenins are the main constituents of Annona muricata
(Moghadamtousi, et al., 2015). In addition to annonaceous acetogenin, phytochemical
screening results from aqueous and ethanol extracts of soursop leaves contain secondary
metabolites such as alkaloids, saponins, terpenoids, flavonoids, coumarins, lactones,
anthraquinones, tannins, cardiac glycosides, phenols and phytosterols (Gavamukulya, et
al., 2014). Zetolite and Annonaceous acetogenin are the main ingredients in the soursop
tree, which have anti-cancer, anti-inflammatory, neuroprotective, anti-Alzheimer's and
anti-oxidant activities (Adri and Hersoelistyorini, 2013). Knowing the affinity and
molecular mechanism of Annona muricata to the COX-2 target protein, can be used to
test the potential of Annona muricata as an anticancer drug using the molecular docking
in silico method (Computer modeling). By identifying and optimizing guide molecules in
the drug discovery process, this computational chemical technique can be utilized to
accelerate the selection of compounds to be isolated and synthesized. As a result, it will
be known the ability of Annona muricata to suppress COX-2 receptor overexpression.
RESEARCH METHOD
The research used descriptive quantitative as a research design and the
Eduvest Journal of Universal Studies
Volume 1 Number 10, October 2021
1198 http://eduvest.greenvest.co.id
experimental factorial design as an approach. The databases used to predict
pharmacokinetics are PubChem, Protein Data Bank, and SwissADME. The structure of
plant chemical compounds can be accessed on PubChem in 2D and 3D but the ones
chosen in this study are in 2D form because not all compounds can read 3D structures on
PubChem. Subsequent research materials are secondary metabolites obtained from the
dr.duke website and target proteins which can be obtained from the Protein Data Bank.
SMILES inputted into PubChem is a chemical notation designed by computer experts that
can be used to interpret a chemical structure accurately and specifically with the help of a
computer (Weininger, 1988). The results are Druglikeness and Boiled Egg data which
will be used to conclude secondary metabolite compounds with good bioavailability.
RESULT AND DISCUSSION
A. Experimental
The databases used to predict pharmacokinetics are PubChem, Protein Data Bank,
and SwissADME. The structure of plant chemical compounds can be accessed on
PubChem in 2D and 3D but the ones chosen in this study are in 2D form because not all
compounds can read 3D structures on PubChem. Subsequent research materials are
secondary metabolites obtained from the dr.duke website and target proteins which can be
obtained from the Protein Data Bank. SMILES inputted into PubChem is a chemical
notation designed by computer experts that can be used to interpret a chemical structure
accurately and specifically with the help of a computer (Weininger, 1988). The results are
Druglikeness and Boiled Egg data which will be used to conclude secondary metabolite
compounds with good bioavailability.
Of the 81 compounds from the Annona muricata tree, analysis was carried out
using the SwissADME webserver using the Boiled Egg method with a range according to
the white circle on TPSA (0-140); WLOGP (-2 6,8). According to (Mirza, 2019) the
Boiled Egg method is able to read two parameters at once, namely Human
Gastrointestinal Absorption (HIA) and Blood Brain Barrier (BBB). The egg plot area can
be easily read, where the yolk represents the physicochemical space for drugs capable of
absorbing BBB and the white space represents the physicochemical space for HIA
absorption.
Figure 1. Boiled Egg
Sofyan Hidayatulloh
Docking Molecular Simulation of Secondary Metabolic Compounds Annona Muricata
as Anti-Cancer 1199
For pharmacodynamic testing, it begins with determining the target protein, in
which the criteria is that the target protein to be used must be included in homo sapiens.
This is because the target protein to be studied is drug interactions in humans. The
selection of the target protein must be complete with ligands because the molecular
docking process can only be done with drugs that have ligands. The docking method is
said to be valid if the RMSD value is 2Å. In table 3, the table of the results of the docking
method validation shows a lot of RMSD this shows that the docking method is valid.
The final result of the docking process is the RMSD value, the number of clusters, the Ki
value and the binding energy that has been inputted in Table 4. The prediction of ligand
interaction activity with the target protein is in the form of binding energy.
The software used for pharmacodynamic profile prediction is Autodock PyRx 0.8
series for docking compounds or drugs, Discovery Studio to separate the contents of the
PDB file and also to visualize the final results in 3D which, for 2D visualization is done
using a webserver. protein.plus. Avogadro is one of the software which has a role in
optimizing the geometry for adjusting the atomic structure and bonds. In addition,
Avogadro also plays a role in stabilizing molecular geometries so that very small changes
in geometry do not change energy (Cahyono, 2019).
The results of the docking simulation carried out 100 times have 100 docking poses
that have their respective bond energies. The bond energy taken is the most negative
because it has a strong interaction. This is due to the presence of polar functional groups
on the ligands such as methyl (-CH3), hydroxyl (-OH) and amine (-NH3).
B. Docking Results Evaluation
The docking simulation in this study was carried out under flexible ligand
conditions. Flexible conditions were used to adjust the structure of the most stable ligand
to interact with the receptor. The stability parameter observed was Gibbs free energy
(∆G). The more negative the value of G indicates a good level of stability between the
ligand and the receptor, so that the bond formed will be stronger. The following table
shows the Gibbs free energy (∆G) of the docking simulation results.
No
Name of compound
Number
of
clusters
Predicted
Binding
Energy
(kcal/mol)
Predicted
Inhibition
constant
1
RETICULINE
3
-9,7
77,87 nM
2
SCYLLITOL
4
-9,85
75,94 nM
3
PROCYANIDIN
6
-9,89
52,97 nM
4
RETICULINE
1
-9,91
51,63 nM
5
GERANYL-CAPROATE
2
-9,8
32,09 nM
6
ARACIDONIC ACID
6
-5,20
154,37
nM
7
Celecoxib
1
-10,11
28,73 nM
Table 1. The best secondary metabolite compound Annona muricate with the smallest
binding energy (∆G) and the largest inhibition constant
The results of the docking simulation carried out 100 times have 100 docking poses
that have their respective bond energies. The bond energy taken is the most negative
because it has a strong interaction. This is due to the presence of polar functional groups
in the ligands such as methyl (-CH3), hydroxyl (-OH) and amine (-NH3) in curcumin
Eduvest Journal of Universal Studies
Volume 1 Number 10, October 2021
1200 http://eduvest.greenvest.co.id
ligands and their analogues.
Secondary metabolite compounds in Annona muricata plant can inhibit arachidonic
acid. This is indicated by the value (∆G) of Annona muricata compound and its analogues
is smaller than that of arachidonic acid (-5.20 kcal/mol). These data indicate that the
Cyclooxyge receptornase-2 (COX-2) will be more stable to bind to compounds in
Annona muricata plant and its analogues than arachidonic acid. Arachidonic acid will
produce prostaglandins due to enzymatic reactions by the Cyclooxsigenase-2 (COX-2)
enzyme so that it can trigger cancer if there is an overexpression of the enzyme.
Celecoxib has a lower G value than Annona muricata compound. This indicates that
celecoxib can bind more stably to the Cyclooxsigenase-2 (COX-2) enzyme receptor
compared to the compound in Annona muricata.
The inhibition constant (Ki) is a value that describes the affinity between the
compound and its decomposition. The smaller the Ki value, the greater the affinity of the
ligand to the receptor (Arfi et al., 2020). From the table above, it can be seen that the
secondary metabolites of Annona muricata have a lower inhibition constant than
arachidonic acid. This shows that high affinity is found in the secondary metabolite
compound Annona muricata. By having a high affinity, there will be inhibition of the
Cyclooxsigenase-2 (COX-2) enzyme, so that prostanoid overproduction can be prevented
and will reduce proliferation and apoptosis in cancer cells (Arfi et al., 2020).
C. Hydrogen Bonds
Observations of hydrogen bonds and amino acids were carried out using the
protein.plus webserver. Chemical bonds other than hydrogen bonds can occur due to
flexible ligands interacting with receptors. Interactions can be in the form of non-covalent
or non-bonded interactions, which occur between the ligand and the receptor, which can
increase the affinity of the ligand to the receptor. The most common bonds are
electrostatic interactions and van der Waals bonds.
Table 2. Hydrogen and Hydrophobic Bonds
No
Name of
compound
Bond Type
Hydrogen
Hydrophobic
1
RETICULINE
Ser339A, Leu338A
Val509A, Gly512A, Leu338A,
Ala513A, Ser339A
2
SCYLLITOL
Ser339A
Val509A, Val335A, Ser339A
3
PROCYANIDIN
Ile503A, Phe504A,
Tyr341A, Gln178A,
Met508A
Val509A, Ser339A, Phe504A,
Gly512A
4
RETICULINE
-
-
5
GERANYL-
CAPROATE
Gln178A, Phe504A,
Tyr341A, Met508A
Phe504A, Gly512A, Val509A,
Ser339A
6
RETICULINE
Gln178A, Phe504A,
Tyr341A, Met508A
Ser339A, Gly512A, Phe504A,
Val509A
Table 2 shows hydrogen bonding and amino acid interactions. Table 2 illustrates
the hydrogen bonds and amino acids that interact between the Cyclooxsigenase-2 (COX-
2) enzyme. The docking simulation can also determine the hydrophobic interaction
between the ligand and the amino acid residue of the Cyclooxsigenase-2 (COX-2)
enzyme in the most stable conformation (small G value).
Sofyan Hidayatulloh
Docking Molecular Simulation of Secondary Metabolic Compounds Annona Muricata
as Anti-Cancer 1201
Figure 2. Visualization of Docking EO (Ethinyl Estradiol)
Figure 3. Visualization of Celecoxib Docking
Observation of residue contacts aims to determine interactions other than hydrogen
bonds that occur between the ligand and the target protein. The residue that makes contact
with the ligand has a non-binding interaction between the ligand and the target protein
which will increase the affinity and inhibitory activity of the Cyclooxsigenase-2 (COX-2)
enzyme. scyllitol has 1 of 2 amino acid residues similar to celecoxib, namely Ser 339A.
This shows that scyllitol compounds have potential as anticancer, which in celecoxib the
sulfonamide group in the hydrophilic pocket attached to the active site of COX-2 is able
to specifically inhibit the COX-2 enzyme.
.
CONCLUSION
Based on the results of this study, it can be concluded that reticuline compounds
have good stability, followed by geranyl-caproate which is seen from the value of binding
energy (∆G). Good secondary metabolite compounds of Annona muricata plant were
shown by reticuline with a value (∆G) of -9.91 kcal/mol. Furthermore, the observation of
hydrogen bonding and amino acid scyllitol showed the similarity of 1 of 2 residues
possessed by celecoxib, which previously had known anticancer activity. It can be
concluded that curcumin and its analogues have potential as anticancer, and can be used
for further drug development related to anticancer.
REFERENCES
Adri, D., Hersoelistyorini, W., 2013. Aktivitas antioksidan dan sifat organoleptik teh
daun sirsak (Annona muricata Linn.) berdasarkan variasi lama pengeringan. J.
Pangan Dan Gizi 4.
Eduvest Journal of Universal Studies
Volume 1 Number 10, October 2021
1202 http://eduvest.greenvest.co.id
Arfi, A.S., Lestari, R.D., Damayanti, D.S., 2020. Studi In Silico Senyawa Aktif Rimpang
Kunyit (Curcuma domestica) Terhadap Penghambatan Acetylcholinesterase,
Microtubulin (beta tubulin), dan Aktivasi Calcium Channel sebagai Terapi
Antelmintik. J. Kedokt. Komunitas 8.
Cahyono, E., n.d. Artikel S1-Intermolecular Force.
Chabner, B.A., Roberts, T.G., 2005. Chemotherapy and the war on cancer. Nat. Rev.
Cancer 5, 6572.
Chen, Z., Krishnamachary, B., Penet, M.-F., Bhujwalla, Z.M., 2018. Acid-degradable
dextran as an image guided siRNA carrier for COX-2 downregulation. Theranostics
8, 1.
Grösch, S., Maier, T.J., Schiffmann, S., Geisslinger, G., 2006. Cyclooxygenase-2 (COX-
2)independent anticarcinogenic effects of selective COX-2 inhibitors. J. Natl.
Cancer Inst. 98, 736747.
Kern, M.A., Haugg, A.M., Koch, A.F., Schilling, T., Breuhahn, K., Walczak, H.,
Fleischer, B., Trautwein, C., Michalski, C., Schulze-Bergkamen, H., 2006.
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and
mitochondria in hepatocellular carcinoma. Cancer Res. 66, 70597066.
Mirza, D.M., 2019. Studi in silico dan in vitro aktivitas antineuroinflamasi ekstrak etanol
96% daun Marsilea crenata C Presl. (undergraduate). Universitas Islam Negeri
Maulana Malik Ibrahim.
Rio, S., Suci, E.S.T., 2017. Persepsi tentang Kanker Serviks dan Upaya Prevensinya pada
Perempuan yang Memiliki Keluarga dengan Riwayat Kanker. J. Kesehat.
Reproduksi 4, 159169.
Siegel, R.L., Miller, K.D., Fedewa, S.A., Ahnen, D.J., Meester, R.G., Barzi, A., Jemal,
A., 2017. Colorectal cancer statistics, 2017. CA. Cancer J. Clin. 67, 177193.
Singh, A.K., Pandey, A., Tewari, M., Prakash, K., Shukla, H.S., Pandey, H.P., 2010. A
DISCUSSION ON CHEMOPREVENTION OF ORAL CANCER BY SELECTIVE
CYCLOOXYGENASE-2 (COX-2) INHIBITORS. Dig. J. Nanomater. Biostructures
DJNB 5.
Sirait, A.M., Sulistiowati, E., 2014. Pengetahuan Tentang Faktor Risiko, Perilaku dan
Deteksi Dini Kanker Serviks dengan Inspeksi Visual Asam Asetat (Iva) pada
Wanita di Kecamatan Bogor Tengah, Kota Bogor. Indones. Bull. Health Res. 42,
20081.